STIRLING Pharmaceuticals is set
to sure up its Canadian presence,
following license approval for a
manufacturing plant in Nova Scotia.
“We are pleased to finally achieve
full licensing of our pharma
manufacturing plant, which now
positions the company to pursue
contract manufacturing revenues,
as well as to commence
formulation and production of a
unique suite of Stirling Health
branded products,” said Stirling
Products md, Peter Boonen.
Plans are now underway for the
new plant to feature capability to
manufacture Stirling branded OTC,
prescription and natural therapies.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jan 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.